e-learning
resources
Vienna 2012
Sunday, 02.09.2012
New mechanisms in non-neoplastic and neoplastic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Reliability of EGFR mutations detection in NSCLC brain metastases by two different allele-specific PCR methods
M. Skronski, P. Krawczyk, K. Wojas-Krawczyk, B. Jarosz, T. Kucharczyk, P. Jagus, M. Sawicki, B. Wilczynska, T. Trojanowski, J. Milanowski, J. Chorostowska-Wynimko (Warsaw, Lublin, Poland)
Source:
Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases
Session:
New mechanisms in non-neoplastic and neoplastic lung diseases
Session type:
Oral Presentation
Number:
1397
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Skronski, P. Krawczyk, K. Wojas-Krawczyk, B. Jarosz, T. Kucharczyk, P. Jagus, M. Sawicki, B. Wilczynska, T. Trojanowski, J. Milanowski, J. Chorostowska-Wynimko (Warsaw, Lublin, Poland). LATE-BREAKING ABSTRACT: Reliability of EGFR mutations detection in NSCLC brain metastases by two different allele-specific PCR methods. Eur Respir J 2012; 40: Suppl. 56, 1397
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Evaluation of highly sensitive PNA-LNA PCR clamp method for EGFR L858R mutation detection in lung adenocarcinoma patients
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
The detection of EGFR mutations in liquid biopsy by allele-specific qPCR – the comparative evaluation of two common diagnostic tests
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Diagnostic utility of PNA-LNA PCR clamp method for detection of EGFR exon 19 deletions and exon 21 codon L858 mutations in NSCLC samples with low tumor cells content
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Quantitative detection of ALK rearrangements using droplet digital PCR (ddPCR) in liquid biopsies of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
LATE-BREAKING ABSTRACT: Novel rapid screening assay for HER2 duplicated insertion mutation by Eprobe-PCR method
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimens
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Noninvasive detection of
EGFR
T790M mutation in gefitinib resistant non-small cell lung cancer using mutant-enriched PCR
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Liquid biopsy for EGFR mutations in non-small cell lung cancer cases by RT-PCR
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Real-time PCR analysis of free-circulating DNA in plasma of non-small cell lung cancer patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Sensitive and specific detection of lung cancer DNA in bronchial washing by a novel methylation-specific droplet digital PCR
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Evaluation of PNA-LNA PCR clamp method sensitivity for detection of key EGFR gene exon 19 and exon 21 mutations
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
Prognosis related gene expression profile in early-stage squamous cell carcinoma of the lung (SqCLC) by real-time quantitative PCR (RT-QPCR)
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
Very early detection of small clones harbouring EGFR mutations in NSCLC by 2nd generation sequencing
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
LSC 2010 Abstract: Real-time PCR quantification of free-circulating plasma DNA in resectable NSCLC and chronic inflammatory respiratory diseases
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer
Source: Eur Respir J 2011; 38: 903-910
Year: 2011
Rapid detection of
M. tuberculosis
gene mutations associated with drug resistance by modified allele-specific real-time PCR
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006
Oncogenic potential of MET SEMA mutations affecting brain metastases from NSCLC is sustained by their microrheological features
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Rapid detection of
M.tuberculosis
drug resistance to second line antibiotics in sputum samples by using the multi-competitive allele-specific real-time PCR
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept